Disease Overview：Tricuspid regurgitation（TR）
Tricuspid regurgitation (TR), or tricuspid valve insufficiency, is a valvular heart disease characterized by improper closure of the tricuspid valve, resulting in retrograde blood flow from the right ventricle to the right atrium during systole. Mild TR is common and often asymptomatic, but moderate-to-severe cases—frequently secondary to right ventricular dilation (e.g., due to pulmonary hypertension, left-sided heart failure, or congenital defects)—can cause fatigue, peripheral edema, ascites, hepatic congestion, and progressive right-heart failure. Diagnosis relies on transthoracic echocardiography (TTE), supplemented by transesophageal echocardiography (TEE), cardiac MRI, or right-heart catheterization when hemodynamic assessment is needed. Management ranges from medical optimization (diuretics, afterload reduction) to surgical intervention—including tricuspid valve repair (annuloplasty) or replacement (bioprosthetic or mechanical)—with transcatheter options (e.g., edge-to-edge repair, annuloplasty devices) emerging for high-risk patients.
China offers distinct advantages for TR treatment: leading cardiovascular centers—such as Fu Wai Hospital (National Center for Cardiovascular Diseases) and Shanghai Ruijin Hospital—boast internationally trained surgeons with extensive experience in complex valve procedures, including minimally invasive and hybrid approaches. Advanced imaging (3D TEE, real-time intraoperative echo), robotic-assisted surgery, and FDA-cleared transcatheter systems are widely deployed. Clinical outcomes align with global benchmarks: >92% 30-day survival for isolated tricuspid surgery and >85% procedural success for transcatheter interventions in recent multicenter registries. Costs are typically 40–60% lower than in the US or Western Europe, without compromising quality—comprehensive packages include diagnostics, surgery, ICU care, and rehabilitation.
As a dedicated medical tourism agency, we streamline the international patient journey: verifying hospital credentials, coordinating appointments with top-tier cardiologists and cardiac surgeons, providing transparent all-inclusive pricing, arranging visas and accommodations, and offering bilingual clinical support and post-discharge follow-up—all tailored to ensure safety, clarity, and continuity of care.
Tricuspid regurgitation: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Tricuspid Regurgitation (Cardiovascular Department)
I. Non-Surgical / Conservative Management
*Indicated for mild-to-moderate TR without right heart failure; asymptomatic patients; or high surgical risk.*
- •Target Criteria: TR grade ≤2+, RV size normal/mildly enlarged, no ascites/jugular venous distension, eGFR ≥60 mL/min
- •Medications (Monthly):
- RAAS inhibitors (e.g., Valsartan 80 mg/day): $25–$35 - Anticoagulation (if AFib + CHA₂DS₂-VASc ≥2): Rivaroxaban 20 mg/day — $45–$65
- •Monitoring (Quarterly):
- BNP/NT-proBNP assay: $28–$35 - Comprehensive metabolic panel + CBC: $42–$55 - 24-h Holter monitoring (if arrhythmia suspected): $110–$140
II. Surgical & Interventional Options
*Indicated for severe (grade 3+/4+) TR with symptoms (fatigue, edema), RV dilation (RVEDD >45 mm), or progressive right heart dysfunction.*
- •Tricuspid Valve Repair (Annuloplasty)
- *Procedure cost (Grade 3A hospital)*: $12,800–$16,500 - *Pre-op workup (mandatory)*: TEE ($260), coronary angiography ($720), pulmonary function test ($95), CT pulmonary angiogram ($310) — Total: $1,385–$1,450
- •Tricuspid Valve Replacement (Mechanical/Bioprosthetic)
- *Procedure cost*: $18,200–$23,600 (mechanical: lower end; bioprosthetic: higher end)
- •Transcatheter Edge-to-Edge Repair (e.g., TriClip™)
- *Procedure cost (device + procedure)*: $29,500–$34,800 - *Pre-op TEE + intraprocedural fluoroscopy guidance*: $380–$450
III. Special/Complex Scenarios
- •TR with Concomitant Left-Sided Valve Surgery: Add-on tricuspid repair during mitral/aortic surgery — + $3,200–$4,100
- •Endocarditis-Related TR: Requires 6-week IV antibiotics (Ceftriaxone + Gentamicin) — $1,400–$1,900, plus urgent valve surgery if abscess or perforation
- •Carcinoid Heart Disease TR: Somatostatin analogs (Octreotide LAR 30 mg/month) — $1,850–$2,200/month
Quick Selection Guide
- •<65 years, severe primary TR, no comorbidities: Surgical repair — optimal durability, lowest long-term cost
- •≥75 years, severe secondary TR, COPD/CKD: Transcatheter repair — avoids sternotomy, faster recovery
- •Mild TR + compensated RV, budget < $500/year: Conservative management with quarterly TTE and diuretic titration
- •TR + active endocarditis or carcinoid syndrome: Urgent multidisciplinary referral — antibiotic therapy or somatostatin analogs precede definitive valve intervention
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Tricuspid regurgitation Medical Vacation Packages
Curated transparent all-inclusive packages combining Tricuspid regurgitation treatment with China top medical destinations:
